Diagnostic and prognostic values of anti glucose-6-phosphate isomerase antibodies in community-recruited patients with very early arthritis

Clinical and Experimental Immunology

Volumn 137, Issue 3, 2004, Pages 606-611

  Jouen, Fabienne ^a,b,c   Vittecoq, O ^a,b   Leguillou, F ^a   Tabti Titon, I ^a   Menard, J F ^b   Mejjad, O ^b   Pouplin, S ^b   Boumier, P ^b   Fardellone, P ^b   Gayet, A ^b   Gilbert, D ^a,b   Tron, F ^a,b   Le Loet X ^a,b  

^a INSERM   (France)

^b AMIENS UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ DE ROUEN   (France)

Author keywords

Anti GPI; Diagnosis; Prognosis; Rheumatoid arthritis

Indexed keywords

ANTIPERINUCLEAR FACTOR; AUTOANTIBODY; C REACTIVE PROTEIN; ENOLASE; GLUCOSE 6 PHOSPHATE ISOMERASE; GLUCOSE 6 PHOSPHATE ISOMERASE ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; KERATIN ANTIBODY; RHEUMATOID FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; IMMUNOFLUORESCENCE; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; POLYMYOSITIS; PRIORITY JOURNAL; PROGNOSIS; RABBIT; RHEUMATOID ARTHRITIS; SERUM; SJOEGREN SYNDROME; SPONDYLOARTHROPATHY; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CASE-CONTROL STUDIES; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUCOSE-6-PHOSPHATE ISOMERASE; HUMANS; MIDDLE AGED; PROGNOSIS;

EID: 4344622305     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02552.x     Document Type: Article

References (43)

1. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:314-24.
2. Vittecoq O, Pouplin S, Krzanowska K et al. Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three-year prospective study in community-recruited patients. Rheumatol 2003; 42:939-46.
3. Bas S, Perneger TV, Seitz M et al. Diagnostic tests for rheumatoid arthritis: comparison of anti-cyclic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factors. Rheumatol 2002; 41:809-14.
4. Goldbach-Mansky R, Lee J, McCoy A et al. Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2000; 2:236-43.
5. Girbal-Neuhauser E, Durieux JJ, Arnaux M et al. The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro) filaggrin by deimination of arginine residues. J Immunol 1999; 162:585-94.
6. Rantappa-Dahlqvist S, De Jong BAW, Berglin E et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003; 48:2741-9.
7. Schellekens GA, Visser H, De Jong BAW et al The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000; 43:155-63.
8. Vincent C, Nogueira L, Sebbag M et al Detection of antibodies to deiminated recombinant rat filaggrin by enzyme-linked immunosorbent assay. A high effective test for the diagnosis of rheumatoid arthritis. Arthritis Rheum 2002; 46:2051-8.
9. Bas S, Genevay S, Meyer O et al. Anti-cyclic citullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis. Rheumatol 2003; 42:677-80.
10. Bas S, Perneger TV, Seitz M et al. Diagnostic tests for rheumatoid arthritis: comparison of anti-cyclic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factor. Rheumatol 2002; 41:809-14.
11. Susuki K, Sawada T, Murakami A et al. high diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis. Scand J Rheumatol 2003; 32:197-204.
12. Lee DM, Schur PH. Clinical utility of the anti-CCP assay in patients with rheumatic diseases. Ann Rheum Dis 2003; 62:870-4.
13. Bizzaro N, Mazzanti G, Tonutti E et al. Diagnostic accuracy of the anticitrulline antibody assay for rheumatoid arthritis. Clin Chem 2001; 47:1089-93.
14. Visser H, Le Cessie S, Vos K et al. How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum 2002; 46:357-65.
15. Vencovsky J, Machacek S, Sedova L et al. Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Ann Rheum Dis 2003; 62:427-30.
16. Forslin K, Vincent C, Serre G et al. Antifilaggrin antibodies in early rheumatoid arthritis may predict radiological progression. Scand J Rheumatol 2001; 30:221-4.
17. Meyer O, Labarre C, Dougados M et al. Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann Rheum Dis 2003; 62:120-6.
18. Kroot EJ, De Jong BA, Van Leeuwen MA et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 2000; 43:1831-5.
19. Matsumoto I, Staub A, Benoist C et al. Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science 1999; 286:1732-5.
20. Solomon S, Kolb C, Mohanty S et al. Transmission of antibody-induced arthritis is independent of complement component 4 (C4) and the complement receptor 1 and 2 (CD21/35). Eur J Immunol 2002; 32:644-51.
21. Ji H, Ohmura K, Mahmood U et al. Arthritis critically dependent on innate immune system players. Immunity 2002; 16:157-68.
22. Ji H, Gauguier D, Ohmura K, Gonzalez A et al. Genetic influences on the end-stage effector phase of arthritis. J Exp Med 2001; 194:321-30.
23. Matsumoto I, Maccioni M, Lee DM et al. How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nature Immunol 2002; 3:360-5.
24. Wipke BT, Wang Z, Kim J et al. Dynamic visualization of a joint-specific autoimmune response through positron emission tomography. Nature Immunol 2002; 3:342-4.
25. Maccioni M, Zeder-Lutz G, Huang H et al. Arthritogenic monoclonal antibodies from K/BxN mice. J Exp Med 2002; 195:1071-7.
26. Schaller M, Burton DR, Ditzel HJ. Autoantibodies to GPI in rheumatoid arthritis: linkage between an animal model and human disease. Nature Immunol 2002; 2:746-53.
27. Matsumoto I, Lee DM, Goldbach-Mansky R et al. Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders. Arthritis Rheum 2003; 48:944-54.
28. Herve CA, Wait R, Venables PJ. Glucose-6-phosphate isomerase is not a specific autoantigen in rheumatoid arthritis. Rheumatology 2003; 42:986-8.
29. Schubert D, Schmidt M, Zaiss D et al. Autoantibodies to GPI and creatine kinase in RA. Nature Immunol 2002; 3:411.
30. Kassahn D, Kolb C, Solomon S et al. Few human autoimmune sera detect GPI. Nature Immunol 2002; 3:411-2.
31. Schaller M, Benoit VM, Ditzel HJ. Response. Nature Immunol 2002; 3:412-3.
32. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25:1271-7.
33. Dougados M, Van Der Linden S, Juhlin R et al. The european spondylarthropathy Study Group, preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991; 34:1218-27.
34. Vitali C, Bombardieri S, Moutsopoulos HM et al. Preliminary criteria for the classification of Sjögren Syndrom. Arthritis Rheum 1993; 36:340-7.
35. Masi AT, Rodnan GP, Medsger TA et al. Preliminary criteria for the classification of systemic sclerosis (sclerodermia). Arthritis Rheum 1980; 23:581-90.
36. Tanimoto K, Nakano K, Kano S et al. Classification criteria for polymyositis and dermatomyositis. J Rheumatol 1995; 22:668-74.
37. Cassidy JT, Levinson JE, Bass JC et al. A study of classification criteria for the diagnosis of juvenil rheumatoid arthritis. Arthritis Rheum 1986; 29:274-81.
38. Youinou P, Le Goff P, Dumay A et al. The antiperinuclear factor 1. Clinical and serological associations. Clin Exp Rheumatol 1990; 8:259-64.
39. Vincent C, Serre G, Lapeyre F et al. High diagnostic value in rheumatoid arthritis of antibodies to the stratum corneum of rat oesophogus epithelium, so-called 'antikeratin antibodies'. Ann Rheum Dis 1989; 48:712-22.
40. Vittecoq O, Jouen-Beades F, Krzanowska K et al. Rheumatoid factors, anti-filaggrin antibodies and low in vitro interleukin-2 and interferon-gamma production are useful immunological markers for early diagnosis of community cases of rheumatoid arthritis. Preliminary study. Joint Bone Spine, 2001; 68:144-53.
41. Saulot V, Vittecoq O, Charlionet R et al. Presence of autoantibodies to the glycolytic enzyme α-enolase in sera from patients with early rheumatoid arthritis. Arthritis Rheum 2002; 46:1196-9.
42. Mouthon L, Haury M, Lacroix-Desmazes S et al. Analysis of the normal human IgG antibody repertoire. Evidence that IgG autoantibodies of healthy adults recognize a limited and conserved set of protein antigens in homologous tissues. J Immunol 1995; 154:5769-78.
43. Kyburz D, Carson DA, Corr M. The role of CD40 ligand and tumor necrosis factor alpha signaling in the transgenic K/BxN mouse model of rheumatoid arthritis. Arthritis Rheum 2000; 43:2571-7.